|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.720 USD | -2.27% |
|
+26.47% | -85.89% |
| 10-08 | Tenax Therapeutics, Inc. Provides Update on Tnx-103 Level and Level-2 Clinical Trials | CI |
| 09-20 | Tenax Therapeutics, Inc.(NasdaqCM:TENX) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TENAX THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -2.27% | +26.47% | -85.89% | -76.73% | -99.93% | 98.52M |  |  | |
- Stock Market
- Stocks
- TENX Stock
- Charts Tenax Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
